The Problem of Benzodiazepine Use and Its Extent in the Driver Population: A Population-Based Registry Study

Frontiers in Pharmacology
Francisco Herrera-GómezF Javier Alvarez

Abstract

Background: Benzodiazepines are driving-impairing medicines (DIM). This study presents current consumption of dispensed benzodiazepines in the Spanish general population, with a focus in pattern of use and concomitant medicines consumed with. Methods: A population-based registry study was carried out to assess the year-2016 granted benzodiazepines dispensation in Castile and León. Weighting was performed to obtain the adjusted benzodiazepine consumption for licensed drivers according to age and gender using our national drivers' license census data. Results: Benzodiazepines were used by 15.38% of the general population and 10.97% of drivers. Nearly 2% of the population and more than 1% of drivers took these medicines every day. The amount consumed (until 3 or more benzodiazepines per day) and concomitant use of other DIM were also higher. Women were the most frequent consumers, and anxiolytic use was usual. Consumption increases with age, but there were differences between men and women drivers from 60 years old. Conclusions: The current use of benzodiazepines must serve to awareness of the healthcare personnel, patients, and authorities on their risks, above all on the road safety.

References

Jan 1, 1996·European Journal of Clinical Pharmacology·N MagriniN Montanaro
Nov 5, 1998·Lancet·F BarboneT M MacDonald
Nov 10, 2006·Journal of Psychopharmacology·Camilla Haw, Jean Stubbs
Aug 11, 2007·International Clinical Psychopharmacology·Sylvie PetitjeanGerhard A Wiesbeck
Dec 7, 2007·International Journal of Geriatric Psychiatry·Jur-Shan ChengYaw-Tang Shih
Mar 4, 2011·Clinical Pharmacology and Therapeutics·L OrriolsUNKNOWN CESIR Research Group
Mar 29, 2012·British Journal of Clinical Pharmacology·Silvia RaveraUNKNOWN DRUID Project WP4 Partners
Sep 6, 2012·Forensic Science International : Synergy·Trinidad Gómez-TalegónF Javier Álvarez
May 6, 2014·Accident; Analysis and Prevention·Toni M RudisillMotao Zhu
Jun 29, 2014·Forensic Science International : Synergy·Karlijn D B BezemerJohan J de Gier
Sep 24, 2016·Neuropsychiatric Disease and Treatment·Wijdan H RamadanMarwan Sheikh-Taha
Mar 4, 2017·The Primary Care Companion to CNS Disorders·Tyler J Dodds
Mar 12, 2017·Trends in Pharmacological Sciences·J G Ramaekers
Apr 14, 2017·International Journal of Clinical Pharmacology and Therapeutics·Thomas MellKarel Kostev
May 12, 2017·Substance Abuse Treatment, Prevention, and Policy·Inmaculada FierroF Javier Álvarez
Jul 26, 2017·Therapeutic Advances in Psychopharmacology·Louis JacobKarel Kostev
Nov 25, 2017·BMJ Open·Eduardo Gutierrez-AbejónF Javier Alvarez
Apr 8, 2018·Drug and Alcohol Dependence·Francisco Herrera-GómezF Javier Álvarez

❮ Previous
Next ❯

Citations

Apr 19, 2019·International Clinical Psychopharmacology·Francisco Herrera-GómezF Javier Álvarez
Dec 11, 2019·Journal of Clinical Medicine·Francisco Herrera-GómezF Javier Álvarez
Feb 26, 2020·Substance Abuse Treatment, Prevention, and Policy·Francisco Herrera-GómezF Javier Álvarez
Sep 6, 2020·British Journal of Clinical Pharmacology·Joanna HockenhullPaul I Dargan
Apr 10, 2021·Fundamental & Clinical Pharmacology·Eduardo Gutiérrez-AbejónFrancisco Javier Álvarez
Jun 1, 2021·Frontiers in Human Neuroscience·Sergio GarbarinoMatteo Riccò
Jul 3, 2021·International Journal of Environmental Research and Public Health·Herng-Ching LinTzong-Hann Yang

❮ Previous
Next ❯

Software Mentioned

Statistical Package for the Social Sciences ( SPSS
SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.